Literature DB >> 9348445

Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.

A Zerilli1, D Ratanasavanh, D Lucas, T Goasduff, Y Dréano, C Menard, D Picart, F Berthou.   

Abstract

4-Nitrophenol 2-hydroxylation activity was previously shown to be mainly catalyzed by P450 2E1 in animal species and humans. As this chemical compound is widely used as an in vitro probe for P450 2E1, this study was carried out to test its catalytic specificity. First, experiments were carried out on liver microsomes and hepatocyte cultures of rat treated with different inducers. Liver microsomes from pyrazole- and dexamethasone-treated rats hydroxylated p-nitrophenol with a metabolic rate increased by 2.5- and 2.7-fold vs control. Dexamethasone treatment increased the hepatic content of P450 3A but not that of P450 2E1. Two specific inhibitors of P450 3A catalytic activities, namely, ketoconazole and troleandomycin (TAO), inhibited up to 50% of 4-nitrophenol hydroxylation in dexamethasone-treated rats but not in controls. Hepatocyte cultures from dexamethasone-treated rats transformed p-nitrophenol into 4-nitrocatechol 7.8 times more than controls. This catalytic activity was inhibited by TAO. Similarly, hepatocyte cultures from pyrazole-treated rats hydroxylated p-nitrophenol with a metabolic ratio increased by about 8-fold vs control. This reaction was inhibited by diethyl dithiocarbamate and dimethyl sulfoxide, both inhibitors of P450 2E1. Second, the capability of human P450s other than P450 2E1 to catalyze the formation of 4-nitrocatechol was examined in a panel of 13 human liver microsomes. Diethyl dithiocarbamate and ketoconazole reduced 4-nitrophenol hydroxylase activity by 77% (+/- 11) and 13% (+/- 16), respectively. Furthermore, the residual activity following diethyl dithiocarbamate inhibition was significantly correlated with seven P450 3A4 catalytic activities. Finally, the use of human cell lines genetically engineered for expression of human P450s demonstrated that P450 2E1 and 3A4 hydroxylated 4-nitrophenol with turnovers of 19.5 and 1.65 min-1, respectively. In conclusion, P450 3A may make a significant contribution to 4-nitrophenol hydroxylase activity in man and rat.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348445     DOI: 10.1021/tx970048z

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  8 in total

1.  Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego.

Authors:  Michael Fairhead; Silva Giannini; Elizabeth M J Gillam; Gianfranco Gilardi
Journal:  J Biol Inorg Chem       Date:  2005-11-09       Impact factor: 3.358

2.  Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates.

Authors:  Jessica H Hartman; H Cass Martin; Andres A Caro; Amy R Pearce; Grover P Miller
Journal:  Toxicology       Date:  2015-10-14       Impact factor: 4.221

3.  Para-nitrophenol hydroxylation by fish liver microsomes: kinetics and effect of selective cytochrome P450 inhibitors.

Authors:  Galia Zamaratskaia; Vladimir Zlabek
Journal:  Fish Physiol Biochem       Date:  2011-05-11       Impact factor: 2.794

4.  Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?

Authors:  Jiang Yue; Renxiu Peng
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

5.  Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes.

Authors:  Giovanna Di Nardo; Andrea Fantuzzi; Anastasia Sideri; Paola Panicco; Carlo Sassone; Carlo Giunta; Gianfranco Gilardi
Journal:  J Biol Inorg Chem       Date:  2007-01-18       Impact factor: 3.862

6.  Acute and Subchronic Toxicity Studies of Aqueous Extract of Desmodium adscendens (Sw) DC.

Authors:  Osbourne Quaye; Precious Cramer; Mark Ofosuhene; Laud K N Okine; Alexander K Nyarko
Journal:  J Evid Based Complementary Altern Med       Date:  2017-11-07

7.  Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.

Authors:  Torsten Diesinger; Vyacheslav Buko; Alfred Lautwein; Radovan Dvorsky; Elena Belonovskaya; Oksana Lukivskaya; Elena Naruta; Siarhei Kirko; Viktor Andreev; Dominik Buckert; Sebastian Bergler; Christian Renz; Edith Schneider; Florian Kuchenbauer; Mukesh Kumar; Cagatay Günes; Berthold Büchele; Thomas Simmet; Dieter Müller-Enoch; Thomas Wirth; Thomas Haehner
Journal:  PLoS One       Date:  2020-07-23       Impact factor: 3.240

8.  Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone.

Authors:  Su-Young Choi; Kwi Hye Koh; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2012-07-26       Impact factor: 3.922

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.